Hepatic organoids for microfluidic drug screening
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
We introduce the microfluidic organoids for drug screening (MODS) platform, a digital microfluidic system that is capable of generating arrays of individually addressable, free-floating, three-dimensional hydrogel-based microtissues (or 'organoids'). Here, we focused on liver organoids, driven by the need for early-stage screening methods for hepatotoxicity that enable a "fail early, fail cheaply" strategy in drug discovery. We demonstrate that arrays of hepatic organoids can be formed from co-cultures of HepG2 and NIH-3T3 cells embedded in hydrogel matrices. The organoids exhibit fibroblast-dependent contractile behaviour, and their albumin secretion profiles and cytochrome P450 3A4 activities are better mimics of in vivo liver tissue than comparable two-dimensional cell culture systems. As proof of principle for screening, MODS was used to generate and analyze the effects of a dilution series of acetaminophen on apoptosis and necrosis. With further development, we propose that the MODS platform may be a cost-effective tool in a "fail early, fail cheaply" paradigm of drug development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Hydrogels as extracellular matrix mimics for 3D cell culture
Tibbitt, M. W., & Anseth, K. S. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22361 · Cited by 2,727
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
The role of matrix stiffness in regulating cell behavior†
Wells, R. G. (2008) · Hepatology · doi:10.1002/hep.22193 · Cited by 1,059
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
Wrighton, S. A., & Stevens, J. C. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145319 · Cited by 944
Inhibition and Induction of Cytochrome P450 and the Clinical Implications
Lin, J. H., & Lu, A. Y. H. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835050-00003 · Cited by 829
Gerets, H. H. J., Tilmant, K., Gerin, B., Chanteux, H., Depelchin, B. O., Dhalluin, S., & Atienzar, F. A. (2012) · Cell Biology and Toxicology · doi:10.1007/s10565-011-9208-4 · Cited by 698
Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels
Tsang, V. L., Chen, A. A., Cho, L. M., Jadin, K. D., Sah, R. L., DeLong, S., West, J. L., & Bhatia, S. N. (2007) · The FASEB Journal · doi:10.1096/fj.06-7117com · Cited by 462
A microfluidic 3D hepatocyte chip for drug toxicity testing
Toh, Y.-C., Lim, T. C., Tai, D., Xiao, G., van Noort, D., & Yu, H. (2009) · Lab on a Chip · doi:10.1039/b900912d · Cited by 419
Research works printed but not linked: 2
- Mugele, 2005, J. Phys.: Condens. Matter, 17, R705
- Fiddes, 2012, Biomicrofluidics, 6
Cited by
Park, S. E., Georgescu, A., & Huh, D. (2019) · Science · doi:10.1126/science.aaw7894 · Cited by 847
Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling
Skardal, A., Shupe, T., & Atala, A. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.07.003 · Cited by 512
“These arrays of 3D organoids had increased liver function compared with 2D controls, and responded to acetaminophen in a drug-screening experiment [28].”
BackgroundMoshksayan, K., Kashaninejad, N., Warkiani, M. E., Lock, J. G., Moghadas, H., Firoozabadi, B., Saidi, M. S., & Nguyen, N.-T. (2018) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2018.01.223 · Cited by 267
Yoon No, D., Lee, K.-H., Lee, J., & Lee, S.-H. (2015) · Lab on a Chip · doi:10.1039/c5lc00611b · Cited by 205
Microfluidic organ-on-a-chip models of human liver tissue
Moradi, E., Jalili-Firoozinezhad, S., & Solati-Hashjin, M. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.08.041 · Cited by 204
Microfluidic Organ‐on‐a‐Chip Technology for Advancement of Drug Development and Toxicology
Caplin, J. D., Granados, N. G., James, M. R., Montazami, R., & Hashemi, N. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500040 · Cited by 205
Microfluidic Gut-liver chip for reproducing the first pass metabolism
Choe, A., Ha, S. K., Choi, I., Choi, N., & Sung, J. H. (2017) · Biomedical Microdevices · doi:10.1007/s10544-016-0143-2 · Cited by 189
Engineering a perfusable 3D human liver platform from iPS cells
Schepers, A., Li, C., Chhabra, A., Seney, B. T., & Bhatia, S. (2016) · Lab on a Chip · doi:10.1039/c6lc00598e · Cited by 176
In Vitro Microfluidic Models for Neurodegenerative Disorders
Osaki, T., Shin, Y., Sivathanu, V., Campisi, M., & Kamm, R. D. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700489 · Cited by 154
Biochemical analysis on microfluidic chips
Wu, J., He, Z., Chen, Q., & Lin, J. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.03.013 · Cited by 162
“The effects of a dilution series of AP on apoptosis and necrosis were analyzed on this device [144].”
MethodCandiello, J., Grandhi, T. S. P., Goh, S. K., Vaidya, V., Lemmon-Kishi, M., Eliato, K. R., Ros, R., Kumta, P. N., Rege, K., & Banerjee, I. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.031 · Cited by 146
Lu, S., Cuzzucoli, F., Jiang, J., Liang, L.-G., Wang, Y., Kong, M., Zhao, X., Cui, W., Li, J., & Wang, S. (2018) · Lab on a Chip · doi:10.1039/c8lc00852c · Cited by 144
Microfluidic Technology for the Generation of Cell Spheroids and Their Applications
Vadivelu, R., Kamble, H., Shiddiky, M., & Nguyen, N.-T. (2017) · Micromachines · doi:10.3390/mi8040094 · Cited by 132
“For instance, digital microfluidic system was developed for drug testing using arrays of liver organoids [127].”
MethodInfluentialLee, J. M., Park, D. Y., Yang, L., Kim, E.-J., Ahrberg, C. D., Lee, K.-B., & Chung, B. G. (2018) · Scientific Reports · doi:10.1038/s41598-018-35216-7 · Cited by 126
Papamichail, L., Koch, L. S., Veerman, D., Broersen, K., & van der Meer, A. D. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1515340 · Cited by 120
Micro Total Analysis Systems: Fundamental Advances and Applications
Patabadige, D. E. W., Jia, S., Sibbitts, J., Sadeghi, J., Sellens, K. A., & Culbertson, C. T. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04310 · Cited by 113
A decade of progress in liver regenerative medicine
Zhang, J., Zhao, X., Liang, L., Li, J., Demirci, U., & Wang, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.027 · Cited by 111
“a digital platform based on microfluidic organoids for drug screening has been developed for 27 testing the dosage effect of acetaminophen on apoptosis of liver organoids [94].”
Liver organoid as a 3D in vitro model for drug validation and toxicity assessment
Brooks, A., Liang, X., Zhang, Y., Zhao, C.-X., Roberts, M. S., Wang, H., Zhang, L., & Crawford, D. H. G. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105608 · Cited by 108
Recent advances in microfluidics for drug screening
Sun, J., Warden, A. R., & Ding, X. (2019) · Biomicrofluidics · doi:10.1063/1.5121200 · Cited by 115
Engineered Microsystems for Spheroid and Organoid Studies
Kang, S., Kim, D., Lee, J., Takayama, S., & Park, J. Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001284 · Cited by 100
Spheroid Engineering in Microfluidic Devices
Tevlek, A., Keçili, S., Ozcelik, O. S., Külah, H., & Tekin, H. C. (2023) · ACS Omega · doi:10.1021/acsomega.2c06052 · Cited by 104
Recent advances in microfluidic 3D cellular scaffolds for drug assays
Wu, J., Chen, Q., Liu, W., He, Z., & Lin, J. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.11.009 · Cited by 99
Kim, S. K., Kim, Y. H., Park, S., & Cho, S.-W. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.002 · Cited by 94
Digital Microfluidic Cell Culture
Ng, A. H. C., Li, B. ‘., Chamberlain, M. D., & Wheeler, A. R. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071114-040808 · Cited by 105
Self-citationDigital Microfluidics for Automated Hanging Drop Cell Spheroid Culture
Aijian, A. P., & Garrell, R. L. (2015) · SLAS Technology · doi:10.1177/2211068214562002 · Cited by 87
“Other work has demonstrated the ability to encapsulate a suspension of cells within hydrogel posts between the plates of a DμF device.(60-62) The encapsulation of cells within hydrogel posts provides a useful tool for modelling cell-matrix interactions, which are key to understanding the cellular microenvironment and…”
Digital microfluidics: A promising technique for biochemical applications
Wang, H., Chen, L., & Sun, L. (2017) · Frontiers of Mechanical Engineering · doi:10.1007/s11465-017-0460-z · Cited by 84
“3D cell cultures can also be conducted in free-floating, hydrogel-based micro-tissues, which are not constricted to pillars [71].”
BackgroundHigh‐Definition Single‐Cell Printing: Cell‐by‐Cell Fabrication of Biological Structures
Zhang, P., & Abate, A. R. (2020) · Advanced Materials · doi:10.1002/adma.202005346 · Cited by 82
Cell-based drug screening on microfluidics
Zhai, J., Yi, S., Jia, Y., Mak, P., & Martins, R. P. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.05.018 · Cited by 80
3D Cell Culture—Can It Be As Popular as 2D Cell Culture?
Sun, M., Liu, A., Yang, X., Gong, J., Yu, M., Yao, X., Wang, H., & He, Y. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202000066 · Cited by 80
Organoids to study immune functions, immunological diseases and immunotherapy
Ye, W., Luo, C., Li, C., Huang, J., & Liu, F. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.027 · Cited by 67
Organ-on-a-Chip Applications in Microfluidic Platforms
An, L., Liu, Y., & Liu, Y. (2025) · Micromachines · doi:10.3390/mi16020201 · Cited by 79
“The microfluidics-based OoC platform not only realizes single-cell omics analysis [27], highly biomimetic organoid culture [28], and multi-organ interaction modeling [1], but also gives rise to intelligent and personalized organ-on-a-chip systems through deep integration with artificial…”
Microfluidic-Based Droplets for Advanced Regenerative Medicine: Current Challenges and Future Trends
Nazari, H., Heirani‐Tabasi, A., Ghorbani, S., Eyni, H., Bazaz, S. R., Khayati, M., Gheidari, F., Moradpour, K., Kehtari, M., Tafti, S. M. A., et al. (2021) · Biosensors · doi:10.3390/bios12010020 · Cited by 63
“Therefore, these droplets can mimic stem cells’ niches and improve complicated cellular complexes [16].”
BackgroundPerspectives on digital microfluidics
Freire, S. L. S. (2016) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2016.08.007 · Cited by 64
Cellular self-assembly and biomaterials-based organoid models of development and diseases
Shah, S. B., & Singh, A. K. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.075 · Cited by 66
Liver Tissue Engineering as an Emerging Alternative for Liver Disease Treatment
Mirdamadi, E. S., Kalhori, D., Zakeri, N., Azarpira, N., & Solati-Hashjin, M. (2020) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2019.0233 · Cited by 57
Digital microfluidics for cell manipulation
Pang, L., Ding, J., Liu, X.-X., & Fan, S. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.06.008 · Cited by 59
Tong, Z., Shen, C., Li, Q., Yin, H., & Mao, H. (2023) · The Analyst · doi:10.1039/d2an01707e · Cited by 56
Vascularized human brain organoid on-chip
Tan, S. Y., Feng, X., Cheng, L. K., & Wu, A. R. (2023) · Lab on a Chip · doi:10.1039/d2lc01109c · Cited by 64
Han, P., Li, X., Yang, J., Zhang, Y., & Chen, J. (2024) · Environment & Health · doi:10.1021/envhealth.4c00043 · Cited by 57
Microfluidics for Antibiotic Susceptibility and Toxicity Testing
Dai, J. H., Hamon, M., & Jambovane, S. R. (2016) · Bioengineering · doi:10.3390/bioengineering3040025 · Cited by 50
“Various organ-on-a-chip devices have been developed, including liver- [89], kidney- [90], lung- [91], intestine- [92], bone marrow- [93] and central-nervous-system-on-a-chip [94].”
Kramer, B., Haan, L. D., Vermeer, M., Olivier, T., Hankemeier, T., Vulto, P., Joore, J., & Lanz, H. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184647 · Cited by 50
“Organ-on-a-chip systems have been proven to be applicable to a wide variety of tissues, such as vasculature, [13,14] brain, [15] kidney [16], and liver [17].”
BackgroundDigital microfluidics for spheroid-based invasion assays
Bender, B. F., Aijian, A. P., & Garrell, R. L. (2016) · Lab on a Chip · doi:10.1039/c5lc01569c · Cited by 49
Shao, W., Xu, H., Zeng, K., Ye, M., Pei, R., & Wang, K. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04139-2 · Cited by 63
Viable cell culture in PDMS-based microfluidic devices
Tanyeri, M., & Tay, S. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.09.007 · Cited by 62
Macaraniag, C., Luan, Q., Zhou, J., & Papautsky, I. (2022) · APL Bioengineering · doi:10.1063/5.0093806 · Cited by 49
Engineered biomimetic hydrogels for organoids
Li, Y., Saiding, Q., Wang, Z., & Cui, W. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101216 · Cited by 47
A Pillar and Perfusion Plate Platform for Robust Human Organoid Culture and Analysis
Kang, S., Kimura, M., Shrestha, S., Lewis, P., Lee, S., Cai, Y., Joshi, P., Acharya, P., Liu, J., Yang, Y., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302502 · Cited by 44
Recent advances in organoid engineering: A comprehensive review
Unagolla, J. M., & Jayasuriya, A. C. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101582 · Cited by 51
Rinkenauer, A. C., Press, A. T., Raasch, M., Pietsch, C., Schweizer, S., Schwörer, S., Rudolph, K. L., Mosig, A. S., Bauer, M. W., Traeger, A., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.008 · Cited by 47
Thyroid‐on‐a‐Chip: An Organoid Platform for In Vitro Assessment of Endocrine Disruption
Carvalho, D. J., Kip, A. M., Romitti, M., Nazzari, M., Tegel, A., Stich, M. I. J., Krause, C., Caiment, F., Costagliola, S., Moroni, L., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201555 · Cited by 47
Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing
Jin, M., Xiao, Y., Liao, W., Chen, Q., Yang, W., Li, Y., Li, S., Gao, Y., Peng, Q., & Zhou, S. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02152-9 · Cited by 43
“Some experts believe that the microfluidic organoids for drug screening platforms may be cost-effective tools for the “fail early, fail cheaply” paradigm of drug development [109].”
BackgroundWu, G., Wu, J., Li, Z., Shi, S., Wu, D., Wang, X., Xu, H., Liu, H., Huang, Y., Wang, R., et al. (2022) · Bio-Design and Manufacturing · doi:10.1007/s42242-022-00188-1 · Cited by 42
“prepared a liver-on-a-chip platform via digital microfluidic technology to evaluate individual 3D liver organoids’ responsiveness to drugs [26].”
BackgroundIn vitro micro-physiological models for translational immunology
Ramadan, Q., & Gijs, M. A. M. (2015) · Lab on a Chip · doi:10.1039/c4lc01271b · Cited by 41
Exploiting CRISPR Cas9 in Three-Dimensional Stem Cell Cultures to Model Disease
Gopal, S., Rodrigues, A. L., & Dordick, J. S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00692 · Cited by 50
“, 2016), perform drug screening using hepatic organoids (Novik et al., 2010; Au et al., 2014; Ortega-Prieto et al., 2018) and to develop 3D cardiac models (Shin et al.”
MethodIn vitro functional models for human liver diseases and drug screening: beyond animal testing
Paradiso, A., Volpi, M., Rinoldi, C., Celikkin, N., Contessi Negrini, N., Bilgen, M., Dallera, G., Pierini, F., Costantini, M., Święszkowski, W., et al. (2023) · Biomaterials Science · doi:10.1039/d1bm01872h · Cited by 40
Toward improved in vitro models of human cancer
Ayuso, J. M., Park, K.-Y., Virumbrales-Muñoz, M., & Beebe, D. J. (2021) · APL Bioengineering · doi:10.1063/5.0026857 · Cited by 40
Signore, M. A., Pascali, C. D., Giampetruzzi, L., Siciliano, P. A., & Francioso, L. N. (2021) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2021.100443 · Cited by 44
Three-Dimensional Bioprinting of Organoids: Past, Present, and Prospective
Cabral, M., Cheng, K., & Zhu, D. (2024) · Tissue Engineering Part A · doi:10.1089/ten.tea.2023.0209 · Cited by 41
Dong, H., Li, Z., Bian, S., Song, G., Song, W., Zhang, M., Xie, H., Zheng, S., Yang, X., Li, T., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.03.020 · Cited by 38
Organoids meet microfluidics: recent advancements, challenges, and future of organoids-on-chip
Chauhdari, T., Zaidi, S. A., Su, J., & Ding, Y. (2025) · In vitro models · doi:10.1007/s44164-025-00086-7 · Cited by 45
“For example, Au et al. developed a novel microfluidic organoid-on-a-chip system (MODS) for hepatotoxicity screening [109].”
Recent advances in liver‐on‐chips: Design, fabrication, and applications
Qiu, L., Kong, B., Kong, T., & Wang, H. (2023) · Smart Medicine · doi:10.1002/smmd.20220010 · Cited by 44
Song, K., Li, G., Zu, X., Du, Z., Liu, L., & Hu, Z. (2020) · Micromachines · doi:10.3390/mi11030297 · Cited by 41
Multi-Organs-on-Chips for Testing Small-Molecule Drugs: Challenges and Perspectives
Çeçen, B., Karavasili, C., Nazir, M., Bhusal, A., Dogan, E., Shahriyari, F., Tamburacı, S., Büyüköz, M., Kozacı, L. D., & Miri, A. K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101657 · Cited by 42
“Automated digital microfluidics proved electro-wetting-based control of hepatic organoids in a microdevice containing a set of electrodes to enumerate the behavior of 3-D hepatic platforms in media droplets and monitor the hepatic functions [50].”
BackgroundEngineered neural circuits for modeling brain physiology and neuropathology
Bang, S., Hwang, K. S., Jeong, S., Cho, I., Choi, N., Kim, J., & Kim, H. N. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.06.024 · Cited by 34
Zeng, X., Ma, Q., Li, X., You, L., Li, J., Fu, X., You, F., & Ren, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1205157 · Cited by 39
“(Au et al., 2014) developed an organoid drug screening platform based on microfluidic technology.”
BackgroundLow, L. A., Sutherland, M. L., Lumelsky, N. L., Selimović, Š., Lundberg, M. S., & Tagle, D. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36588-2_3 · Cited by 37
Heterotypic 3D tumor culture in a reusable platform using pneumatic microfluidics
Liu, W., Tian, C., Yan, M., Zhao, L. Q., Ma, C., Li, T., Xu, J., & Wang, J. (2016) · Lab on a Chip · doi:10.1039/c6lc00996d · Cited by 34
Electromembrane Extraction and Mass Spectrometry for Liver Organoid Drug Metabolism Studies
Skottvoll, F. S., Hansen, F. A., Harrison, S. P., Boger, I. C. S., Mrsa, A., Restan, M. S., Stein, M., Lundanes, E., Pedersen‐Bjergaard, S., Aizenshtadt, A., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c05082 · Cited by 34
A decade of liver organoids: Advances in disease modeling
Liu, Y., Sheng, J.-Y., Yang, C.-F., Ding, J., & Chan, Y.-S. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0428 · Cited by 30
Microfluidic Cell Trapping for Single-Cell Analysis
Deng, B., Wang, H., Tan, Z., & Quan, Y. (2019) · Micromachines · doi:10.3390/mi10060409 · Cited by 30
Kothamachu, V. B., Zaini, S., & Muffatto, F. (2020) · SLAS TECHNOLOGY · doi:10.1177/2472630320931794 · Cited by 39
“112 The integration of sample preparation protocols on the device allows a DMF platform to work with a variety of samples, like blood serum, 108,109 plasma, 101,112 whole-blood samples, 76,113 solids like tissues, 109,114 dried blood, 90,115 hydrogels, 116,117 and monoliths.”
Method3D Hepatic Organoid-Based Advancements in LIVER Tissue Engineering
Panwar, A., Das, P., & Tan, L. P. (2021) · Bioengineering · doi:10.3390/bioengineering8110185 · Cited by 36
“Further, the effect of acetaminophen on necrosis and apoptosis using a microfluidic platform was also studied [59].”
MethodLiu, X., Ma, D., Ye, H., Hou, Y., Bai, X., Xing, Y., Cheng, X., Lin, B., & Lu, Y. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117153 · Cited by 30
George, S. M., & Moon, H. (2015) · Biomicrofluidics · doi:10.1063/1.4918377 · Cited by 30
A Microfluidic Chip Embracing a Nanofiber Scaffold for 3D Cell Culture and Real-Time Monitoring
Kim, J. H., Park, J. Y., Jin, S., Yoon, S., Kwak, J.-Y., & Jeong, Y. H. (2019) · Nanomaterials · doi:10.3390/nano9040588 · Cited by 32
“Their platform showed better results than 2D cell culture systems in drug screening [14].”
BackgroundGuo, K., & van den Beucken, T. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01317-2 · Cited by 28
“Au et al. [115].”
In Vitro Intestinal and Liver Models for Toxicity Testing
Orbach, S. M., Less, R. R., Kothari, A., & Rajagopalan, P. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00699 · Cited by 31
High-throughput solutions in tumor organoids: from culture to drug screening
Zuo, J., Fang, Y., Wang, R., & Liang, S. (2024) · Stem Cells · doi:10.1093/stmcls/sxae070 · Cited by 33
“20 Examples of such solutions include using microfluidics for organoid implantation, 15 automated robots for drug treatment and detection, 21 high-resolution imaging for cell state analysis, and data analysis software for result processing.”
Sui, M., Dong, H., Mu, G., Yang, Z., Ai, Y., & Zhao, J. (2024) · Advanced Science · doi:10.1002/advs.202409394 · Cited by 27
State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC
Liu, M., Xiang, Y., Yang, Y., Long, X., Xiao, Z., Nan, Y., Jiang, Y., Qiu, Y., Huang, Q., & Ai, K. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114758 · Cited by 28
Rapid spheroid clearing on a microfluidic chip
Santisteban, T. S., Rabajania, O., Kalinina, I. M., Robinson, S. P., & Meier, M. (2017) · Lab on a Chip · doi:10.1039/c7lc01114h · Cited by 35
Simulation and modeling of physiological processes of vital organs in organ-on-a-chip biosystem
Seidi, S., Eftekhari, A., Khusro, A., Heris, R. S., Sahibzada, M. U. K., & Gajdács, M. (2021) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2021.101710 · Cited by 30
Liu, J., Li, R., Xue, R., Li, T., Leng, L., Wang, Y., Wang, J., Ma, J., Yan, J., Yan, F., et al. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800110 · Cited by 23
Stem cell‐derived organoids to model gastrointestinal facets of cystic fibrosis
Hohwieler, M., Perkhofer, L., Liebau, S., Seufferlein, T. T. W., Müller, M., Illing, A., & Kleger, A. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640616670565 · Cited by 23
“Microfluidic systems hold great potential and could revolutionise the organoid screening technology already proven on hepatic organoids and by highthroughput platform using in vitro stem cell niches.(129,130) In summary, high-throughput screening organoid platforms are currently in development for clinical application…”
Microfabricated Physiological Models for In Vitro Drug Screening Applications
Ugolini, G. S., Cruz‐Moreira, D., Visone, R., Redaelli, A. C. L., & Rasponi, M. (2016) · Micromachines · doi:10.3390/mi7120233 · Cited by 25
“Interestingly, differences in enzymatic activity were not detectable after treatment of standard monolayers of hepatocytes while significant alterations of enzymatic activity were reported in 3D constructs cultured within the microfluidic device [29].”
BackgroundCreating rat hepatocyte organoid as an in vitro model for drug testing
He, Y.-T., Zhu, X.-L., Li, S.-F., Zhang, B.-Q., Li, Y., Wu, Q., Zhang, Y.-L., Zhou, Y.-Y., Li, L., Qi, Y.-N., et al. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i10.1184 · Cited by 22
Microscale 3D Liver Bioreactor for In Vitro Hepatotoxicity Testing under Perfusion Conditions
Freyer, N., Greuel, S., Knöspel, F., Gerstmann, F., Storch, L., Damm, G., Seehofer, D., Harris, J. F., Iyer, R. S., Schubert, F., et al. (2018) · Bioengineering · doi:10.3390/bioengineering5010024 · Cited by 26
“This observation might be explained by a shift to necrotic cell death, in accordance with findings by Au and colleagues, who observed a transition from apoptosis to necrosis between 10 and 20 mM APAP exposure using HepG2 cells [47].”
BackgroundResultMicrotechnology-based in vitro models: Mimicking liver function and pathophysiology
Lee, S. Y., Kim, D., Sung, J. H., & Sung, J. H. (2021) · APL Bioengineering · doi:10.1063/5.0061896 · Cited by 24
Open and closed microfluidics for biosensing
Ge, T., Hu, W., Zhang, Z., He, X., Wang, L., Han, X., & Dai, Z. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101048 · Cited by 23
“…of astrocystin concentration using both DMF and conventional techniques, and found a 33-fold reduction in reagent consumption with DMF. Au et al. [103] developed a microfluidic organoids for drug screening platform that uses digital microfluidics to create and analyze miniature…”
MethodMicrofluidic analysis of heterotypic cellular interactions: A review of techniques and applications
Sakthivel, K., O’Brien, A., Kim, K., & Hoorfar, M. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.03.026 · Cited by 24
Development of 3D Hepatic Constructs Within Polysaccharide-Based Scaffolds with Tunable Properties
Labour, M.-N., Guilcher, C. L., Aid, R., Samad, N. E., Lanouar, S., Simón‐Yarza, T., & Letourneur, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103644 · Cited by 27
“Importantly, hepatic organoid technology combined with microfluidic devices enabled high throughput screening for drug toxicity studies and improved in vitro models of liver fibrosis or tumor microenvironments [19,30,31].”
BackgroundSathyanarayanan, G., Haapala, M., Dixon, C., Wheeler, A. R., & Sikanen, T. M. (2020) · Advanced Materials Technologies · doi:10.1002/admt.202000451 · Cited by 21
Self-citationRecent advances in the development of in vitro liver models for hepatotoxicity testing
Lu, S., Zhang, J., Lin, S., Zheng, D., Shen, Y., Qin, J., Li, Y. Y., & Wang, S. (2021) · Bio-Design and Manufacturing · doi:10.1007/s42242-021-00142-7 · Cited by 25
Organoids: Principle, application and perspective
Liu, K., Fang, X., Aazmi, A., Wang, Q., Gong, X., Chen, Z., Qin, M., Pu, C., Zhao, Y., Qiu, X., et al. (2024) · The Innovation Life · doi:10.59717/j.xinn-life.2024.100088 · Cited by 23
Zhang, C., Zhang, Q., Li, J., Yu, L. C., Li, F., Li, W., Li, Y., Peng, H., Zhao, J. Y., Carmichael, P. L., et al. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104661 · Cited by 20
PCB Escape Routing and Layer Minimization for Digital Microfluidic Biochips
McDaniel, J., Zimmerman, Z., Grissom, D. T., & Brisk, P. (2016) · IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems · doi:10.1109/tcad.2016.2568199 · Cited by 20
“tions including cryopreservation [27], single-cell analysis [29], immunoassays [32], point-of-care diagnostics [21], [25], [26], drug screening [1], and many others.”
BackgroundPeng, X., Wang, B., Yang, Y., Zhang, Y., Liu, Y., He, Y., Zhang, C., & Fan, H. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01630 · Cited by 20
Lee, J., Jung, S., Hong, H. K., Jo, H., Rhee, S., Jeong, Y., Ko, J., Cho, Y. B., & Jeon, N. L. (2024) · Lab on a Chip · doi:10.1039/d3lc01055d · Cited by 18
Active-matrix digital microfluidics for high-throughput, precise droplet handling
Wang, D., Jiang, S., Ma, H., Yu, J., & Nathan, A. (2025) · Nature Reviews Electrical Engineering · doi:10.1038/s44287-025-00230-1 · Cited by 23
“For instance, high-throughput drug screening involves the large-scale and rapid testing of extensive libraries of chemical compounds 129 , which substantially accelerates the drug discovery process.”
Toward Organs on Demand: Breakthroughs and Challenges in Models of Organogenesis
Francipane, M. G., & Lagasse, E. (2016) · Current Pathobiology Reports · doi:10.1007/s40139-016-0111-9 · Cited by 19
Metadata
- Authors
- Au, S. H., Chamberlain, M. D., Mahesh, S., Sefton, M. V., & Wheeler, A. R.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Wheeler, Aaron R.
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014-07-02
- Volume
- 14
- Issue
- 17
- Pages
- 3290
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2041356700
- Cited by
- 162
- References
- 50
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 16 · 2023: 11 · 2022: 9 · 2021: 16 · 2020: 21 · 2019: 17 · 2018: 12 · 2017: 15 · 2016: 17 · 2015: 7 · 2014: 3
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- liver organoids, microfluidic organoids, hepatotoxicity screening, HepG2 cells, NIH3T3 cells, co-culture, CYP3A4, albumin secretion, fibroblast contraction, acetaminophen toxicity, apoptosis, necrosis, 3D cell culture, drug discovery
- MeSH terms
- Animals, Pharmaceutical Preparations, Humans, Liver, NIH 3T3 Cells, Microfluidic Analytical Techniques, Mice, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.